Vargas SJ, Skromne-Kadlubik G, Hidalgo-Rico R

Language: Spanish
References: 5
Page: 96-98
PDF size: 94.71 Kb.

ABSTRACT

We obtained antibodies against transforming growth factor-beta type (TGF-β) with the method described in a previous publication. In two homogeneous groups of diabetes mellitus type II (previously of diabetic nephropathy) we use this antibodies in one group and compared in the other group the results in six months of clinical and laboratorial follow-up using renal profiles with an statistical results of 0.01 for the use of antibodies against TGF that protect the patients from diabetic nephropathy in an harmless form.

REFERENCES

1. Reeves WB, Androlite E. Transforming growth factor β contributes to progressive diabetic nephropathy. Proc Natl Acad Sci USA 2000; 97: 7667-9.

2. Sharina K, Zyadeh FN. The emerging role of transforming growth factor β in kidney disease. Am J Physiol 1994; 2661: 829-92.

3. Massague J. The transforming growth factor β family. Anna Rev Cell Biol 1990; 6: 597-641.

4. Davenport HW. The ABC of acid-base chemistry. University of Chicago Press 1994.

5. Alvarez CJ, Skromne-Kadlubik G. Labell of DDD-I-131. j. Inter Applied Isotopes 1973; 24: 187.